WILLIAM LEE: Open Payments
NPI 1770019515 · MARION, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 16 payments from 8 companies in 2025. Trend: 2023 $209 · 2024 $184 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $199 |
| Alpha Cognition USA, Inc. | 1 | $169 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Dexcom, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Zunveyl, BREZTRI, AUSTEDO XR, AIRSUPRA, REXULTI, Ozempic, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across AL — which companies pay providers there.
